Cargando…
Proton magnetic resonance spectroscopy of lung cancer in vivo
Proton magnetic resonance spectroscopy ((1)H-MRS) has demonstrated that in vitro, lung cancer has higher lactate and choline signals than those of normal tissues. The detection of these metabolites in lung cancer in vivo by (1)H-MRS would be useful for clinical diagnoses of lung cancer. We report th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256246/ https://www.ncbi.nlm.nih.gov/pubmed/32489513 http://dx.doi.org/10.1016/j.radcr.2020.05.018 |
Sumario: | Proton magnetic resonance spectroscopy ((1)H-MRS) has demonstrated that in vitro, lung cancer has higher lactate and choline signals than those of normal tissues. The detection of these metabolites in lung cancer in vivo by (1)H-MRS would be useful for clinical diagnoses of lung cancer. We report the in vivo detection of lactate and choline in lung cancer by (1)H-MRS in a 41-year-old Asian man who was diagnosed with pT4N0M0 ⅢA stage, right upper lobe lung adenocarcinoma. A lactate-lipid peak was observed near 1.33 ppm in the spectrum of lung cancer in vivo at TE = 30 ms, and it was inverted at TE = 135 ms, indicating that a lactate signal is contained in the lactate-lipid peak. A choline peak was also observed near 3.2 ppm in the spectrum with fat suppression at TE = 135 ms. An accumulation of similar cases will help determine the appropriate applications of (1)H-MRS for lung cancer. |
---|